ROBBIE LOWERY: Open Payments
NPI 1306097845 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$289 in 12 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $22 · 2025 $289
Food & beverage: $289
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 2 | $54 |
| Amneal Pharmaceuticals LLC | 2 | $40 |
| Lilly USA, LLC | 2 | $35 |
| SK Life Science, Inc. | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $32 |
| Solventum Corporation | 1 | $28 |
| ARGENX US, INC. | 1 | $26 |
| Genentech USA, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $18 |
Products named: Rystiggo, CREXONT, KISUNLA, KESIMPTA, PREVENA, VYVGART HYTRULO, Ocrevus Zunovo, BOTOX.
Industry payments across TN — which companies pay providers there.
